VIM and pulmonary fibrosis: In the bleomycin-induced pulmonary fibrosis model, cytomegalovirus is considered to accelerate existing fibrosis according to enhancing TGFB1 activation and the expression of both phospho-SMAD2 and Vimentin (38).